![]() |
|
|
Vol. 16, Issue 8, 3800-3809, August 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mediates Endothelial Cell Proliferation and Is Inactivated by Association with the Golgi Apparatus
School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, United Kingdom
Submitted February 25, 2005;
Revised April 27, 2005;
Accepted May 24, 2005
Monitoring Editor: Vivek Malhotra
Arachidonic acid and its metabolites are implicated in regulating endothelial cell proliferation. Cytosolic phospholipase A2-
(cPLA2
) is responsible for receptor-mediated arachidonic acid evolution. We tested the hypothesis that cPLA2
activity is linked to endothelial cell proliferation. The specific cPLA2
inhibitor, pyrrolidine-1, inhibited umbilical vein endothelial cell (HUVEC) proliferation in a dose-dependent manner. Exogenous arachidonic acid addition reversed this inhibitory effect. Inhibition of sPLA2 did not affect HUVEC proliferation. The levels of cPLA2
did not differ between subconfluent and confluent cultures of cells. However, using fluorescence microscopy we observed a novel, confluence-dependent redistribution of cPLA2
to the distal Golgi apparatus in HUVECs. Association of cPLA2
with the Golgi was linked to the proliferative status of HUVECs. When associated with the Golgi apparatus, cPLA2
activity was seen to be 87% inhibited. Relocation of cPLA2
to the cytoplasm and nucleus, and cPLA2
enzyme activity were required for cell cycle entry upon mechanical wounding of confluent monolayers. Thus, cPLA2
activity and function in controlling endothelial cell proliferation is regulated by reversible association with the Golgi apparatus.
Abbreviations used: AA, arachidonic acid; BFA, brefeldin A; cPLA2
, cytosolic phospholipase A2-
; ERGIC-53, endoplasmic reticulum-Golgi intermediate compartment-53; GalT,
-1,4-galactosyltransferase; HUVEC, human umbilical vein endothelial cell; iPLA2, calcium-independent phospholipase A2; ManII, mannosidase II; sPLA2, secretory phospholipase A2
Address correspondence to: J. H. Walker (j.h.walker{at}leeds.ac.uk).
This article has been cited by other articles:
![]() |
E. Regan-Klapisz, V. Krouwer, M. Langelaar-Makkinje, L. Nallan, M. Gelb, H. Gerritsen, A. J. Verkleij, and J. A. Post Golgi-associated cPLA2{alpha} Regulates Endothelial Cell-Cell Junction Integrity by Controlling the Trafficking of Transmembrane Junction Proteins Mol. Biol. Cell, October 1, 2009; 20(19): 4225 - 4234. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Jopling, A. F. Odell, N. M. Hooper, I. C. Zachary, J. H. Walker, and S. Ponnambalam Rab GTPase Regulation of VEGFR2 Trafficking and Signaling in Endothelial Cells Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1119 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Herbert, A. F. Odell, S. Ponnambalam, and J. H. Walker Activation of Cytosolic Phospholipase A2-{alpha} as a Novel Mechanism Regulating Endothelial Cell Cycle Progression and Angiogenesis J. Biol. Chem., February 27, 2009; 284(9): 5784 - 5796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Murphy, R. S. Vohra, S. Dunn, Z. G. Holloway, A. P. Monaco, S. Homer-Vanniasinkam, J. H. Walker, and S. Ponnambalam Oxidised LDL internalisation by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2 J. Cell Sci., July 1, 2008; 121(13): 2136 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cubells, S. V. de Muga, F. Tebar, J. V. Bonventre, J. Balsinde, A. Pol, T. Grewal, and C. Enrich Annexin A6-induced Inhibition of Cytoplasmic Phospholipase A2 Is Linked to Caveolin-1 Export from the Golgi J. Biol. Chem., April 11, 2008; 283(15): 10174 - 10183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Pla, C. Grange, S. Antoniotti, C. Tomatis, A. Merlino, B. Bussolati, and L. Munaron Arachidonic Acid-Induced Ca2+ Entry Is Involved in Early Steps of Tumor Angiogenesis Mol. Cancer Res., April 1, 2008; 6(4): 535 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Mishra, K. A. Carnevale, and M. K. Cathcart iPLA2{beta}: front and center in human monocyte chemotaxis to MCP-1 J. Exp. Med., February 18, 2008; 205(2): 347 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Herbert, A. F. Odell, S. Ponnambalam, and J. H. Walker The Confluence-dependent Interaction of Cytosolic Phospholipase A2-{alpha} with Annexin A1 Regulates Endothelial Cell Prostaglandin E2 Generation J. Biol. Chem., November 23, 2007; 282(47): 34468 - 34478. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mariggio, J. Sebastia, B. M. Filippi, C. Iurisci, C. Volonte, S. Amadio, V. De Falco, M. Santoro, and D. Corda A novel pathway of cell growth regulation mediated by a PLA2{alpha}-derived phosphoinositide metabolite FASEB J, December 1, 2006; 20(14): 2567 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Herbert and J. H. Walker Group VIA Calcium-independent Phospholipase A2 Mediates Endothelial Cell S Phase Progression J. Biol. Chem., November 24, 2006; 281(47): 35709 - 35716. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Barnes, H. Dobrzynski, S. Foppolo, P. R. Beal, F. Ismat, E. R. Scullion, L. Sun, J. Tellez, M. W.L. Ritzel, W. C. Claycomb, et al. Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH Circ. Res., September 1, 2006; 99(5): 510 - 519. [Abstract] [Full Text] [PDF] |
||||